Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Combination of Evidence from Bibliometrics and Bioinformatics Analysis Identifies miR-21 as a Potential Therapeutical Target for Diabetes

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Information:
      MDPI AG, 2024.
    • Publication Date:
      2024
    • Collection:
      LCC:Microbiology
    • Abstract:
      Many microRNAs (miRNAs) have been identified as being involved in diabetes; however, the question of which ones may be the most promising therapeutical targets still needs more investigation. This study aims to understand the overall development tendency and identify a specific miRNA molecule to attenuate diabetes. We developed a combined analysis method based on bibliometrics and bioinformatics to visualize research institutions, authors, cited references, and keywords to identify a promising target for diabetes. Our data showed that diabetes-related miRNA is receiving continuously increasing attention, with a large number of publications, indicating that this is still a hot topic in diabetes research. Scientists from different institutions are collaborating closely in this field. miR-21, miR-146a, miR-155, and miR-34a are frequently mentioned as high-frequency keywords in the related references. Moreover, among all the above miRNAs, bioinformatics analysis further strengthens the argument that miR-21 is the top significantly upregulated molecule in diabetes patients and plays an important role in the pathogenesis of diabetes. Our study may provide a way to identify targets and promote the clinical translation of miRNA-related therapeutical strategies for diabetes, which could also indicate present and future directions for research in this area.
    • File Description:
      electronic resource
    • ISSN:
      2218-1989
    • Relation:
      https://www.mdpi.com/2218-1989/14/8/403; https://doaj.org/toc/2218-1989
    • Accession Number:
      10.3390/metabo14080403
    • Accession Number:
      edsdoj.fc78ff7128ba4d18932620bcdf721e2d